Sort by 'likes'
Issues faced by Young Adult Cancer Survivors
According to the National Cancer Institute, there are more young adults today being diagnosed with cancer than any other age group in the United States, making it the number one disease killer amongst the young adults. In this show we…
The MMRF Precision Medicine Model – How Close to Multiple Myeloma Cure Are We?
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated pillars fueled by data generation and integration; collaboration and discovery; and accelerating clinical trials. Integrating this model…
Advances in Parkinson’s Disease Management
Parkinson's disease is a neurological disorder that affects the ability of a person to control body movements. It is caused by loss of nerve cells in the region of the brain that produces the neurotransmitter dopamine. Dopamine, the messenger between…
Immunotherapy Advances in Multiple Myeloma
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody therapies. antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes,…
Transplants and Risk Adapted Maintenance in Myeloma Treatment
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or…